Cary Street Partners Investment Advisory’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-800
| Closed | -$36.3K | – | 865 |
|
|
2023
Q3 | $36.3K | Hold |
800
| – | – | ﹤0.01% | 951 |
|
|
2023
Q2 | $44.9K | Hold |
800
| – | – | ﹤0.01% | 844 |
|
|
2023
Q1 | $36.2K | Sell |
800
-550
| -41% | -$24.9K | ﹤0.01% | 820 |
|
|
2022
Q4 | $54.9K | Buy |
+1,350
| New | +$54.9K | ﹤0.01% | 717 |
|
|
2022
Q3 | – | Sell |
-1,850
| Closed | -$112K | – | 515 |
|
|
2022
Q2 | $112K | Buy |
+1,850
| New | +$112K | 0.01% | 496 |
|